株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

皮下薬物投与デバイスの世界市場:技術、シリンジタイプ、流通チャネル、地域別 - 2027年までの予測および分析

Subcutaneous Drug Delivery Devices Market to 2027 - Global Analysis and Forecasts by Technology ; Syringe Type ; Distribution Channel and Geography

発行 The Insight Partners 商品コード 913824
出版日 ページ情報 英文 157 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
皮下薬物投与デバイスの世界市場:技術、シリンジタイプ、流通チャネル、地域別 - 2027年までの予測および分析 Subcutaneous Drug Delivery Devices Market to 2027 - Global Analysis and Forecasts by Technology ; Syringe Type ; Distribution Channel and Geography
出版日: 2019年09月16日 ページ情報: 英文 157 Pages
概要

世界の皮下ドラッグデリバリー装置市場は、2018年に92億4,380万米ドルとなりました。同市場は、2019年から2027年の間に7.4%のCAGRで成長する見通しで、2027年には172億9,047万米ドルに達すると予測されています。

当レポートは世界の皮下ドラッグデリバリー装置市場について調査しており、市場機会や動向、成長および阻害要因、技術・シリンジタイプ・流通チャネル・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 イントロダクション

  • 調査範囲
  • The Insight Partners調査レポートのガイダンス
  • 市場セグメント

第2章 要点

第3章 調査方法

  • 調査範囲
  • 二次調査
  • 一次調査

第4章 市況

  • 概要
  • PEST分析
  • 専門家の意見

第5章 主要産業力学

  • 主な市場阻害要因
    • 慢性疾患の増加率
    • 製薬および医療機器企業の研究開発費の増加
    • 技術の進歩、増加する製品の発売
  • 主な市場阻害要因
    • 注射に関連するリスク
  • 主な市場機会
    • 患者コンプライアンスごとの製品の開発
  • 今後の動向
    • 共同研究による製品革新の成長
    • プレフィルド生理食塩水シリンジの迅速な採用
  • 影響分析

第6章 世界の市場分析

  • 市場の収益予測/分析
  • 市場予測/分析:地域別
  • 主要企業の市場における位置づけ

第7章 市場分析および予測:技術

  • 概要
  • 市場シェア(2018年・2027年)
  • シリンジ

第8章 市場分析および予測:シリンジのタイプ別

  • 概要
  • 市場シェア(2018年・2027年)
  • プレフィルド
  • フィラブル

第9章 市場分析および予測:流通チャネル別

  • 概要
  • 市場シェア(2018年・2027年)
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第10章 市場分析および予測:地域別

  • 北米
  • 技術別
  • シリンジタイプ別
  • 流通チャネル別
  • 欧州

第11章 アジア太平洋地域

  • 概要
  • アジア太平洋地域
  • 技術別
  • シリンジタイプ別
  • 流通チャネル別
  • 国別予測
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国

第12章 中東およびアフリカ

  • 概要
  • 中東・アフリカ
  • 技術別
  • シリンジタイプ別
  • 流通チャネル別
  • 国別予測
  • 南アフリカ
  • サウジアラビア
  • UAE

第13章 中南米

  • 概要
  • 中南米
  • 技術別
  • シリンジタイプ別
  • 流通チャネル別
  • 国別予測
  • ブラジル

第14章 競合情勢

  • 概要
  • 市場の企業が行った成長戦略
  • 有機的開発
  • 無機的開発

第15章 企業プロファイル

  • Insulet Corporation
  • BD
  • Amgen Inc.
  • ELCAM Medical
  • Ypsomed AG
  • West Pharmaceutical Services, Inc
  • Scpharmaceuticals, Inc.
  • Wilhelm Haselmeier GmbH and Co. KG
  • Consort Medical PLC
  • Enable Injections, Inc.

第16章 付録

  • The Insight Partnersについて
  • 用語集
図表

LIST OF TABLES

  • Table 1. R&D Investments by Major Pharmaceutical Companies
  • Table 2. North America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 3. North America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
  • Table 4. North America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
  • Table 5. US Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 6. US Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
  • Table 7. US Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
  • Table 8. Canada Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 9. Canada Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
  • Table 10. Canada Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
  • Table 11. Mexico Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 12. Mexico Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
  • Table 13. Mexico Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
  • Table 14. Europe Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 15. Europe Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
  • Table 16. Europe Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
  • Table 17. UK Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 18. UK Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
  • Table 19. UK Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
  • Table 20. Germany Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 21. Germany Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
  • Table 22. Germany Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
  • Table 23. France Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 24. France Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
  • Table 25. France Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
  • Table 26. Italy Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 27. Italy Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
  • Table 28. Italy Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
  • Table 29. Spain Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 30. Spain Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
  • Table 31. Spain Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
  • Table 32. Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 33. Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
  • Table 34. Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
  • Table 35. Japan Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 36. Japan Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
  • Table 37. Japan Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
  • Table 38. China Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 39. China Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
  • Table 40. China Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
  • Table 41. India Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 42. India Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
  • Table 43. India Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
  • Table 44. Australia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 45. Australia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
  • Table 46. Australia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
  • Table 47. South Korea Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 48. South Korea Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
  • Table 49. South Korea Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
  • Table 50. Middle East and Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 51. Middle East and Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
  • Table 52. Middle East and Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
  • Table 53. South Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 54. South Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
  • Table 55. South Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
  • Table 56. Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 57. Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
  • Table 58. Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
  • Table 59. UAE Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 60. UAE Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
  • Table 61. UAE Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
  • Table 62. South and Central America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 63. South and Central America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
  • Table 64. South and Central America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
  • Table 65. Brazil Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 66. Brazil Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
  • Table 67. Brazil Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
  • Table 68. Argentina Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 69. Argentina Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
  • Table 70. Argentina Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
  • Table 71. Organic Developments Done By Companies
  • Table 72. Inorganic developments done by Companies
  • Table 73. Glossary Of Terms, Subcutaneous Drug Delivery Devices Market

LIST OF FIGURES

  • Figure 1. Subcutaneous Drug Delivery Devices Market Segmentation
  • Figure 2. Subcutaneous Drug Delivery Devices Segmentation, By Region
  • Figure 3. Global Subcutaneous Drug Delivery Devices Market Overview
  • Figure 4. Fillable Injectable Segment Held Largest Share Of The Syringe Type Segment In Subcutaneous Drug Delivery Devices Market
  • Figure 5. North America Region Is Expected To Show Remarkable Growth During The Forecast Period
  • Figure 6. Global Subcutaneous Drug Delivery Devices Market, By Geography (US$ Mn)
  • Figure 7. Global Subcutaneous Drug Delivery Devices Market- Leading Country Markets (US$ Mn)
  • Figure 8. Global Subcutaneous Drug Delivery Devices Market, Industry Landscape
  • Figure 9. North America : PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific PEST Analysis
  • Figure 12. Middle East & Africa PEST Analysis
  • Figure 13. South & Central America PEST Analysis
  • Figure 14. Global Subcutaneous Drug Delivery Devices Market - Revenue Forecasts And Analysis - 2018- 2027
  • Figure 15. Global Subcutaneous Drug Delivery Devices Market - By Geography Forecasts And Analysis - 2018- 2027
  • Figure 16. Global Subcutaneous Drug Delivery Devices Market - Market Positioning
  • Figure 17. Global Subcutaneous Drug Delivery Devices Market Share By Technology 2018 & 2027 (%)
  • Figure 18. Syringes Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 19. Pens Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 20. Patches Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 21. Others Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 22. Global Subcutaneous Drug Delivery Devices Market Share by Syringe Type 2018 & 2027 (%)
  • Figure 23. Prefilled Injectable Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 24. Fillable Injectable Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 25. Global Subcutaneous Drug Delivery Devices Market Share by Distribution Channel 2018 & 2027 (%)
  • Figure 26. Hospital Pharmacies Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 27. Retail Pharmacies Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 28. Online Pharmacies Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 29. North America Subcutaneous Drug Delivery Devices Market Revenue Overview, by Country, 2018 (US$ Mn)
  • Figure 30. North America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 31. North America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 32. US Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 33. Canada Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 34. Mexico Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 35. Europe Subcutaneous Drug Delivery Devices Market Revenue Overview, by Country, 2018 (US$ MN)
  • Figure 36. Europe Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 37. Europe Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 38. UK Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 39. Germany Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 40. France Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 41. Italy Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 42. Spain Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 43. Asia Pacific Subcutaneous Drug Delivery Devices Market Overview, by Country (2017)
  • Figure 44. Asia Pacific Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 45. Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 46. Japan Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 47. China Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 48. India Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 49. Australia Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 50. South Korea Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 51. Middle East & Africa Subcutaneous Drug Delivery Devices Market Overview, by Country (2018)
  • Figure 52. Middle East & Africa Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 53. Middle East & Africa Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 54. South Africa Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 55. Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 56. UAE Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 57. South and Central America Subcutaneous Drug Delivery Devices Market Overview, by Country (2018)
  • Figure 58. South and Central America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 59. South and Central America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 60. Brazil Subcutaneous Drug Delivery Devices Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 61. Argentina Subcutaneous Drug Delivery Devices Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 62. Growth Strategies done by the companies in the Market, (%)
目次
Product Code: TIPRE00006411

The global subcutaneous drug delivery devices market is expected to reach US$ 17,290.47 Mn in 2027 from US$ 9,243.80 in 2018. The market is estimated to grow with a CAGR of 7.4% from 2019-2027.

The increased number of chronic disease prevalence around the globe, significant number of vaccination and immunization programs that incorporate the use of subcutaneous drug delivery devices for therapeutic administration, rise in the research and development of new products leading to the subsequent introduction of novel solutions and devices in the market are expected to account for the growth of the market. However, risk of infections and other diseases associated with the use of injections and syringes is likely to hamper the market growth.

Research and development (R&D) is an essential and crucial part of the company's business. Pharmaceutical and medical devices companies focus on the research and development (R&D) to come up with new molecules for various therapeutic applications with the greatest medical and commercial potential. The companies invest majorly on the R&Ds with the aim of delivering high quality and innovative products to the market. R&D spending by the biopharmaceutical companies has also increased over the years. According to a report of Pharmaceutical Research and Manufacturers of America (PhRMA), the R&D expenditure of the biopharmaceutical companies has increased from US$49.6 billion 2012 to US$ 58.8 billion in 2015. Also, Evonik Corporation has invested more than $50 million over the last 4 years to advance its competencies in medical devices, and production of RESOMER polymers for drug delivery and bio-reabsorbable medical devices. Thus the growing R&D expenditure drives the subcutaneous drug delivery systems market during the forecast period.

The global subcutaneous drug delivery devices market, based on the technology was segmented into syringes, pens, patches and others. In 2018, the syringes segment held the largest share of the market, by technology. However, the patches segmented is anticipated to witness fastest growth in the subcutaneous drug delivery devices market, based on technology. In the recent years, the increasing use of single-use syringes have helped to successfully reduce the rates of cross contamination thereby propelling the growth of syringes in the subcutaneous drug delivery devices market in the coming years.

Some of the major primary and secondary sources included in the report for the subcutaneous drug delivery devices Market are the World Health Organization, Organization For Economic Co-Operation And Development, Centers for Disease Control and Prevention, National Health Services, National Center for Biotechnology Information, Japan Chronic Disease Self-Management Association, Council Of Scientific And Industrial Research, and others.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the subcutaneous drug delivery devices market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global subcutaneous drug delivery devices market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Subcutaneous Drug Delivery Devices Market - By Technology
    • 1.3.2 Global Subcutaneous Drug Delivery Devices Market - By Syringe Type
    • 1.3.3 Global Subcutaneous Drug Delivery Devices Market - By Distribution Channel
    • 1.3.4 Global Subcutaneous Drug Delivery Devices Market - By Geography

2. Global Subcutaneous Drug Delivery Devices Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Subcutaneous Drug Delivery Devices- Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific - PEST Analysis
    • 4.2.4 Middle East & Africa- PEST Analysis
    • 4.2.5 South & Central America - PEST Analysis
  • 4.3 Expert Opinions

5. Global Subcutaneous Drug Delivery Devices Market - Key Industry Dynamics

    • 5.1.1 Increasing Incidence of Chronic Diseases
    • 5.1.2 Increasing R&D Expenditures in Pharmaceutical And Medical Device Companies
    • 5.1.3 Technological Advancements and Increasing Product Launches
  • 5.2 Key Market Restraints
    • 5.2.1 Risks Associated with Injections:
  • 5.3 Key Market Opportunities
    • 5.3.1 Development of Products As Per Patient Compliance
  • 5.4 Future Trends
    • 5.4.1 Growing Product Innovations through Collaborative Research:
    • 5.4.2 Rapid Adoption of Pre-Filled Saline Syringes
  • 5.5 Impact Analysis

6. Subcutaneous Drug Delivery Devices Market - Global Analysis

  • 6.1 Global Subcutaneous Drug Delivery Devices Market Revenue Forecasts And Analysis
  • 6.2 Global Subcutaneous Drug Delivery Devices Market, By Geography - Forecasts And Analysis
  • 6.3 Market Positioning of Key Players

7. Subcutaneous Drug Delivery Devices Market Analysis And Forecasts To 2027 - Technology

  • 7.1 Overview
  • 7.2 Global Subcutaneous Drug Delivery Devices Market Share by Technology 2018 & 2027 (%)
  • 7.3 Syringes Market
    • 7.3.1 Overview
    • 7.3.2 Syringes Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.3.3 Pens
      • 7.3.3.1 Overview
      • 7.3.3.2 Pens Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.3.4 Patches
      • 7.3.4.1 Overview
      • 7.3.4.2 Patches Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.3.5 Others
      • 7.3.5.1 Overview
      • 7.3.5.2 Others Market Revenue and Forecast to 2027 (US$ Mn)

8. Subcutaneous Drug Delivery Devices Market Analysis And Forecasts To 2027 - Syringe Type

  • 8.1 Overview
  • 8.2 Global Subcutaneous Drug Delivery Devices Market Share by Syringe Type 2018 & 2027 (%)
  • 8.3 Prefilled Injectable Market
    • 8.3.1 Overview
    • 8.3.2 Prefilled Injectable Market Revenue and Forecast to 2027 (US$ Mn)
  • 8.4 Fillable Injectable Market
    • 8.4.1 Overview
    • 8.4.2 Fillable Injectable Market Revenue and Forecast to 2027 (US$ Mn)

9. Subcutaneous Drug Delivery Devices Market Analysis And Forecasts To 2027 - Distribution Channel

  • 9.1 Overview
  • 9.2 Global Subcutaneous Drug Delivery Devices Market Share by Distribution Channel 2018 & 2027 (%)
  • 9.3 Hospital Pharmacies Market
    • 9.3.1 Overview
    • 9.3.2 Hospital Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)
  • 9.4 Retail Pharmacies Market
    • 9.4.1 Overview
    • 9.4.2 Retail Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)
  • 9.5 Online Pharmacies Market
    • 9.5.1 Overview
    • 9.5.2 Online Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)

10. Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 - Geographical Analysis

  • 10.1 North America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts To 2027
    • 10.1.1 North America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
  • 10.2 North America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • 10.3 North America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
  • 10.4 North America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
    • 10.4.1 North America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)
    • 10.4.2 US Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.4.2.1 US Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.4.2.2 US Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 10.4.2.3 US Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
      • 10.4.2.4 US Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
    • 10.4.3 Canada Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.4.3.1 Canada Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.4.3.2 Canada Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 10.4.3.3 Canada Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
      • 10.4.3.4 Canada Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
    • 10.4.4 Mexico Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.4.4.1 Mexico Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.4.4.2 Mexico Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 10.4.4.3 Mexico Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
      • 10.4.4.4 Mexico Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
  • 10.5 Europe Subcutaneous Drug Delivery Devices Market Revenue And Forecasts To 2027
    • 10.5.1 Europe Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
  • 10.6 Europe Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • 10.7 Europe Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
  • 10.8 Europe Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
    • 10.8.1 Europe Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)
    • 10.8.2 UK Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.8.2.1 UK Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.8.2.2 UK Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 10.8.2.3 UK Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
      • 10.8.2.4 UK Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
    • 10.8.3 Germany Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.8.3.1 Germany Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.8.3.2 Germany Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 10.8.3.3 Germany Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
      • 10.8.3.4 Germany Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
    • 10.8.4 France Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.8.4.1 France Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.8.4.2 France Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 10.8.4.3 France Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
      • 10.8.4.4 France Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
    • 10.8.5 Italy Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.8.5.1 Italy Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.8.5.2 Italy Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 10.8.5.3 Italy Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
      • 10.8.5.4 Italy Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
    • 10.8.6 Spain Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.8.6.1 Spain Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.8.6.2 Spain Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 10.8.6.3 Spain Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
      • 10.8.6.4 Spain Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

11. Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027

  • 11.1 Overview
  • 11.2 Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
  • 11.3 Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • 11.4 Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
  • 11.5 Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
  • 11.6 Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)
  • 11.7 Japan Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
    • 11.7.1 Japan Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.7.1.1 Japan Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 11.7.1.2 Japan Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
      • 11.7.1.3 Japan Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
  • 11.8 China Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
    • 11.8.1 China Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.8.1.1 China Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 11.8.1.2 China Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
      • 11.8.1.3 China Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
  • 11.9 India Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
    • 11.9.1 India Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.9.1.1 India Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 11.9.1.2 India Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
      • 11.9.1.3 India Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
  • 11.10 Australia Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
    • 11.10.1 Australia Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.10.1.1 Australia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 11.10.1.2 Australia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
      • 11.10.1.3 Australia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
  • 11.11 South Korea Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
    • 11.11.1 South Korea Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.11.1.1 South Korea Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 11.11.1.2 South Korea Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
      • 11.11.1.3 South Korea Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

12. Middle East & Africa Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027

  • 12.1 Overview
  • 12.2 Middle East & Africa Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
  • 12.3 Middle East and Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • 12.4 Middle East and Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
  • 12.5 Middle East and Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
  • 12.6 Middle East & Africa Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)
  • 12.7 South Africa Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
    • 12.7.1 South Africa Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
      • 12.7.1.1 South Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 12.7.1.2 South Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
      • 12.7.1.3 South Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
  • 12.8 Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
    • 12.8.1 Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
      • 12.8.1.1 Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 12.8.1.2 Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
      • 12.8.1.3 Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
  • 12.9 UAE Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
    • 12.9.1 UAE Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
      • 12.9.1.1 UAE Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 12.9.1.2 UAE Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
      • 12.9.1.3 UAE Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

13. South and Central America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027

  • 13.1 Overview
  • 13.2 South and Central America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
  • 13.3 South and Central America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • 13.4 South and Central America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
  • 13.5 South and Central America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
  • 13.6 South and Central America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)
  • 13.7 Brazil Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
      • 13.7.1.1 Brazil Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
      • 13.7.1.2 Brazil Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 13.7.1.3 Brazil Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
      • 13.7.1.4 Brazil Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
    • 13.7.2 Argentina Subcutaneous Drug Delivery Devices Market
      • 13.7.2.1 Argentina Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
      • 13.7.2.2 Argentina Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 13.7.2.3 Argentina Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
      • 13.7.2.4 Argentina Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

14. Subcutaneous Drug Delivery Devices Market - Industry Landscape

  • 14.1 Overview
  • 14.2 Growth Strategies done by the companies in the Market, (%)
  • 14.3 Organic Developments
    • 14.3.1 Overview
  • 14.4 Inorganic developments
    • 14.4.1 Overview

15. Subcutaneous Drug Delivery Devices Market - Key Company Profiles

  • 15.1 Insulet Corporation
    • 15.1.1 Key Facts
    • 15.1.2 Business Description
    • 15.1.3 Financial Information
    • 15.1.4 Product Portfolio
    • 15.1.5 SWOT Analysis
    • 15.1.6 Key Developments
  • 15.2 BD
    • 15.2.1 Key Facts
    • 15.2.2 Business Description
    • 15.2.3 Financial Overview
    • 15.2.4 Product Portfolio
    • 15.2.5 SWOT Analysis
    • 15.2.6 Key Developments
  • 15.3 Amgen Inc.
    • 15.3.1 Key Facts
    • 15.3.2 Business Description
    • 15.3.3 Financial Overview
    • 15.3.4 Product Portfolio
    • 15.3.5 SWOT Analysis
    • 15.3.6 Key Developments
  • 15.4 ELCAM Medical
    • 15.4.1 Key Facts
    • 15.4.2 Business Description
    • 15.4.3 Financial Overview
    • 15.4.4 Product Portfolio
    • 15.4.5 SWOT Analysis
    • 15.4.6 Key Developments.
  • 15.5 Ypsomed AG
    • 15.5.1 Key Facts
    • 15.5.2 Business Description
    • 15.5.3 Financial Information
    • 15.5.4 Product Portfolio
    • 15.5.5 SWOT Analysis
    • 15.5.6 Key Developments
  • 15.6 West Pharmaceutical Services, Inc
    • 15.6.1 Key Facts
    • 15.6.2 Business Description
    • 15.6.3 Financial Information
    • 15.6.4 Product Portfolio
    • 15.6.5 SWOT Analysis
    • 15.6.6 Key Developments
  • 15.7 Scpharmaceuticals, Inc.
    • 15.7.1 Key Facts
    • 15.7.2 Business Description
    • 15.7.3 Financial Overview
    • 15.7.4 Product Portfolio
    • 15.7.5 SWOT Analysis
    • 15.7.6 Key Developments.
  • 15.8 Wilhelm Haselmeier GmbH and Co. KG
    • 15.8.1 Key Facts
    • 15.8.2 Business Description
    • 15.8.3 Financial Overview
    • 15.8.4 Product Portfolio
    • 15.8.5 SWOT Analysis
    • 15.8.6 Key Developments
  • 15.9 Consort Medical PLC
    • 15.9.1 Key Facts
    • 15.9.2 Business Description
    • 15.9.3 Financial Overview
    • 15.9.4 Product Portfolio
    • 15.9.5 SWOT Analysis
    • 15.9.6 Key Developments
  • 15.10 Enable Injections, Inc.
    • 15.10.1 Key Facts
    • 15.10.2 Business Description
    • 15.10.3 Financial Overview
    • 15.10.4 Product Portfolio
    • 15.10.5 SWOT Analysis
    • 15.10.6 Key Developments

16. Appendix

  • 16.1 About The Insight Partners
  • 16.2 Glossary Of Terms
Back to Top